The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays
Open accessAbstract
Merkel cell polyomavirus (MCV) is a newly‐discovered human tumor virus found in ∼80% of Merkel cell carcinoma (MCC). The rate of MCV infection among persons without MCC is unknown. We developed a MCV virus‐like particle (VLP) enzyme‐linked immunoassay (EIA) that does not cross‐react with human BK or murine polyomaviruses. Peptide mapping of the MCV VP1 gene and immunoblotting with denatured MCV VLP are less sensitive than the MCV EIA in detecting MCV antibodies suggesting antibody reactivity in this assay primarily targets conformational but not linear epitopes. Among MCC patients, all 21 (100%) patients tested with MCV‐positive tumors had high serum MCV IgG but not high MCV IgM levels. Only 3 of 6 (50%) MCC patients with MCV‐negative tumors were positive for MCV antibodies. Sera from most adults, including 107 of 166 (64%) blood donors, 63 of 100 (63%) commercial donors and 37 of 50 (74%) systemic lupus erythematosus patients, show evidence for prior MCV exposure. Age‐specific MCV prevalence was determined by examining a cross‐sectional distribution of 150 Langerhans cell histiocytosis (an unrelated neoplasm) patient sera. MCV prevalence increases from 50% among children age 15 years or younger to 80% among persons older than 50 years. We did not find evidence for vertical transmission among infants. Although past exposure to MCV is common among all adult groups, MCC patients have a markedly elevated MCV IgG response compared with control patients. Our study demonstrates that MCV is a widespread but previously unrecognized human infection. © 2009 UICC
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
Feng, H., Shuda, M., Chang, Y., & Moore, P. S. (2008) · Science · doi:10.1126/science.1152586 · Cited by 3,208
Self-citationA Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus
Shuda, M., Feng, H., Kwun, H. J., Rosen, S. T., Gjoerup, O., Moore, P. S., & Chang, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806526105 · Cited by 728
Self-citationIdentification of a Novel Polyomavirus from Patients with Acute Respiratory Tract Infections
Gaynor, A. M., Nissen, M. D., Whiley, D. M., Mackay, I. M., Lambert, S. B., Wu, G., Brennan, D. C., Storch, G. A., Sloots, T. P., & Wang, D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030064 · Cited by 707
Identification of a Third Human Polyomavirus
Allander, T., Andreasson, K., Gupta, S., Bjerkner, A., Bogdanovic, G., Persson, M. A. A., Dalianis, T., Ramqvist, T., & Andersson, B. (2007) · Journal of Virology · doi:10.1128/jvi.00028-07 · Cited by 659
Merkel cell carcinoma and HIV infection
Engels, E. A., Frisch, M., Goedert, J. J., Biggar, R. J., & Miller, R. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07668-7 · Cited by 550
Efficient Intracellular Assembly of Papillomaviral Vectors
Buck, C. B., Pastrana, D. V., Lowy, D. R., & Schiller, J. T. (2004) · Journal of Virology · doi:10.1128/jvi.78.2.751-757.2004 · Cited by 489
Self-citationShuda, M., Arora, R., Kwun, H. J., Feng, H., Sarid, R., Fernández‐Figueras, M., Tolstov, Y., Gjoerup, O., Mansukhani, M. M., Swerdlow, S. H., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24510 · Cited by 373
Self-citationMC Polyomavirus Is Frequently Present in Merkel Cell Carcinoma of European Patients
Becker, J. C., Houben, R., Ugurel, S., Trefzer, U., Pföhler, C., & Schrama, D. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.198 · Cited by 372
Self-citationKassem, A., Schöpflin, A., Diaz, C., Weyers, W., Stickeler, E., Werner, M., & zur Hausen, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0949 · Cited by 369
Cited by
Why do viruses cause cancer? Highlights of the first century of human tumour virology
Moore, P. S., & Chang, Y. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2961 · Cited by 745
Self-citationBecker, J. C., Stang, A., DeCaprio, J. A., Cerroni, L., Lebbé, C., Veness, M., & Nghiem, P. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.77 · Cited by 645
Self-citationSchowalter, R. M., Pastrana, D. V., Pumphrey, K. A., Moyer, A. L., & Buck, C. B. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.05.006 · Cited by 594
Self-citationMerkel cell carcinoma: Current US incidence and projected increases based on changing demographics
Paulson, K. G., Park, S. Y., Vandeven, N. A., Lachance, K., Thomas, H., Chapuis, A. G., Harms, K. L., Thompson, J. A., Bhatia, S., Stang, A., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.10.028 · Cited by 528
Viral hijacking of cellular metabolism
Thaker, S. K., Ch’ng, J., & Christofk, H. R. (2019) · BMC Biology · doi:10.1186/s12915-019-0678-9 · Cited by 526
Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens
Houben, R., Shuda, M., Weinkam, R., Schrama, D., Feng, H., Chang, Y., Moore, P. S., & Becker, J. C. (2010) · Journal of Virology · doi:10.1128/jvi.02400-09 · Cited by 457
Self-citationMerkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs
Schadendorf, D., Lebbé, C., zur Hausen, A., Avril, M.-F., Hariharan, S., Bharmal, M., & Becker, J. C. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.10.022 · Cited by 397
Self-citationShuda, M., Arora, R., Kwun, H. J., Feng, H., Sarid, R., Fernández‐Figueras, M., Tolstov, Y., Gjoerup, O., Mansukhani, M. M., Swerdlow, S. H., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24510 · Cited by 373
Self-citationHuman polyomaviruses in disease and cancer
Dalianis, T., & Hirsch, H. H. (2013) · Virology · doi:10.1016/j.virol.2012.12.015 · Cited by 321
The biology and treatment of Merkel cell carcinoma: current understanding and research priorities
on behalf of the International Workshop on Merkel Cell Carcinoma Research (IWMCC) Working Group, Harms, P. W., Harms, K. L., Moore, P. S., DeCaprio, J. A., Nghiem, P., Wong, M. K. K., & Brownell, I. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0103-2 · Cited by 316
Self-citationQuantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus
Pastrana, D. V., Tolstov, Y. L., Becker, J. C., Moore, P. S., Chang, Y., & Buck, C. B. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000578 · Cited by 254
Self-citationMucin biopolymers as broad-spectrum antiviral agents
Lieleg, O., Lieleg, C., Bloom, J., Buck, C. B., & Ribbeck, K. (2012) · Biomacromolecules · doi:10.1021/bm3001292 · Cited by 167
Self-citationLi, J., Wang, X., Diaz, J., Tsang, S. H., Buck, C. B., & You, J. (2013) · Journal of Virology · doi:10.1128/jvi.01216-13 · Cited by 128
Self-citationMerkel cell carcinoma: an updated review focused on bone and bone marrow metastases
Scotti, B., Broseghini, E., Ricci, C., Corti, B., Viola, C., Misciali, C., Baraldi, C., Vaccari, S., Lambertini, M., Venturi, F., et al. (2025) · Cancers · doi:10.3390/cancers17132253 · Cited by 9
Merkel cell polyomavirus protein ALTO modulates TBK1 activity to support persistent infection
Wang, R., Senay, T. E., Luo, T. T., Liu, W., Regan, J. M., Salisbury, N. J. H., Galloway, D. A., & You, J. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1012170 · Cited by 9
Metadata
- Authors
- Tolstov, Y. L., Pastrana, D. V., Feng, H., Becker, J. C., Jenkins, F. J., Moschos, S., Chang, Y., Buck, C. B., & Moore, P. S.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2009-07-14
- Volume
- 125
- Issue
- 6
- Pages
- 1250-1256
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2141975379
- Cited by
- 339
- References
- 22
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.